Nov 10 (Reuters) - Intervacc AB IVACC.ST :
* INTERIM REPORT JANUARY - SEPTEMBER 2022
* Q3 NET SALES AMOUNTED SEK 2.0 MILLION (1.3)
* FOR Q3 OPERATING RESULT AMOUNTED TO SEK -14.6 MILLION
(-8.3)
* NEGATIVE OPERATING RESULT IS MAINLY EXPLAINED BY FACT THAT
SALE
OF GROUP'S FIRST IN-HOUSE DEVELOPED PRODUCT, STRANGVAC, IS IN A
START-UP PHASE AND THAT AFTER LAUNCH COMPANY BEGAN DEPRECIATION
ON BALANCED DEVELOPMENT COSTS
Source text for Eikon: ID:nWkr2pVqPD
Further company coverage: IVACC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))